Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin
US10793641B2 · kind B2 · utility
4Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2016 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Oct 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/03
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.